Skip to main content
Back

Comprehensive Study Notes: Principles of Disease, Pathogenicity, Immunity, Vaccines, and Antimicrobial Drugs

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Principles of Disease

Modes of Disease Transmission

Understanding how diseases are transmitted is essential for controlling and preventing infections. Transmission can occur through various routes, each with distinct mechanisms.

  • Contact Transmission: Direct physical contact between individuals (e.g., touching, kissing).

  • Droplet Transmission: Spread via respiratory droplets expelled during coughing, sneezing, or talking. Droplets typically travel short distances (less than 1 meter).

  • Vehicle Transmission: Involves transmission through a non-living medium such as air, water, or food. This does not involve direct organism-to-organism transfer.

  • Airborne Transmission: Pathogens are carried on dust or droplet nuclei suspended in air, traveling longer distances than droplets.

  • Animal Vectors: Arthropods (e.g., ticks, fleas, mosquitoes, flies) can transmit pathogens.

    • Mechanical Transmission: The vector carries the pathogen on its body surface.

    • Biological Transmission: The pathogen reproduces within the vector and is transmitted via bites or feces.

Table 14.3: (Comparison of mechanical vs. biological transmission.)

Transmission Type

Mechanism

Example Vector

Mechanical

Pathogen carried externally

Housefly

Biological

Pathogen develops inside vector

Mosquito (malaria)

Healthcare Acquired Infections (HAIs)

HAIs, also known as nosocomial infections, originate in healthcare settings and are a significant cause of morbidity and mortality.

  • Origin: Can arise from the hospital environment, staff, or other patients.

  • Harm: HAIs can complicate treatment, prolong hospital stays, and increase healthcare costs.

  • Common Examples: Urinary tract infections (catheters), surgical site infections, pneumonia (ventilators).

Table 14.4: (Examples and sites of HAIs.)

Infection Type

Common Site

Associated Procedure

UTI

Urinary tract

Catheterization

Pneumonia

Lungs

Ventilator use

Surgical Site Infection

Incision site

Surgery

Table 14.5: (Transmission routes in healthcare settings.)

Route

Example

Staff to Patient

Improper hand hygiene

Patient to Staff

Needlestick injury

Patient to Patient

Shared equipment

Epidemiology

Epidemiology is the study and analysis of disease patterns in defined populations.

  • Case Reporting: Systematic documentation of disease cases to monitor and control outbreaks.

  • Nationally Notifiable Diseases: Certain infectious diseases must be reported to health authorities (see Table 14.6 for examples).

Microbial Mechanisms of Pathogenicity

Pathogenicity and Virulence

Pathogenicity is the ability of a microorganism to cause disease, while virulence refers to the degree of pathogenicity.

  • Requirements for Pathogenicity: Entry into the host, growth, causing damage, and evading host defenses.

  • Virulence Factors: Traits that enhance a pathogen's ability to cause disease (e.g., toxins, capsules).

Entry Portals for Pathogens

Pathogens enter the host through specific portals, which can be breached by trauma or medical procedures.

  • Common Portals: Mucous membranes, skin, parenteral route (injection, bites).

Table 15.1: (Entry portals and examples.)

Portal

Example Pathogen

Respiratory tract

Influenza virus

Gastrointestinal tract

Salmonella spp.

Skin

Staphylococcus aureus

Infectious Dose (ID50) vs. Lethal Dose (LD50)

These metrics quantify pathogen virulence.

  • ID50: Infectious dose for 50% of the population.

  • LD50: Lethal dose for 50% of the population.

  • Lower values indicate higher virulence.

Virulence Factors

  • Adhesins: Surface molecules that bind to host receptors, facilitating attachment.

  • Capsules: Polysaccharide layers that inhibit phagocytosis.

  • Cell Wall Components: Such as M protein, which resists phagocytosis.

  • Antigenic Variation: Pathogens alter surface proteins to evade immune detection.

  • Exoenzymes: Enzymes that degrade host tissues.

    • Coagulases: Clot fibrinogen, protecting bacteria from immune cells.

    • Kinases: Digest clots; e.g., streptokinase used to treat heart attacks.

    • Hyaluronidase: Breaks down connective tissue.

    • Collagenase: Degrades collagen in connective tissue.

  • Invasins & Siderophores: Facilitate invasion and iron acquisition.

  • Toxins: Substances that damage host cells.

    • Exotoxins: Secreted proteins; highly toxic and specific.

    • Endotoxins: Lipopolysaccharide components of Gram-negative bacteria; released upon cell death.

Table 15.2 & 15.3: (Types and effects of toxins.)

Toxin Type

Source

Effect

Exotoxin

Gram-positive bacteria

Specific tissue damage

Endotoxin

Gram-negative bacteria

Fever, shock

Innate Immunity

Definitions and Overview

Innate immunity is the body's first line of defense, providing immediate, non-specific protection against pathogens.

  • Immunity: Ability to resist infection.

  • Susceptibility: Lack of resistance to disease.

  • Resistance: Ability to ward off disease.

  • Cytokines: Signaling proteins that regulate immune responses.

Features of the Immune System

  • Physical and chemical barriers

  • Recognition of pathogens

  • Distinguishing self from non-self

  • Memory (mainly adaptive immunity)

  • Regulation to prevent overreaction

Innate vs. Adaptive Immunity

  • Innate Immunity: Non-specific, immediate response.

  • Adaptive Immunity: Specific, slower response with memory.

Physical and Chemical Barriers

  • First Line Defense: Skin, tears, mucus prevent pathogen entry.

  • Chemical Factors: Lysozyme in tears, acidic pH of skin and stomach.

Second Line Defense

  • Blood Components: Plasma, cells (leukocytes).

  • Leukocytes:

    • Monocytes/Macrophages: Phagocytosis.

    • Dendritic Cells: Antigen presentation.

    • Neutrophils: Phagocytosis, first responders.

    • Basophils: Release histamine.

    • Eosinophils: Combat parasites, allergic responses.

Blood Separation: Technique to analyze blood components; white blood cell count can indicate infection or immune status.

Lymphatic System

  • Lymph: Fluid containing immune cells.

  • Lymph Vessels: Transport lymph; related to but separate from blood vessels.

  • Lymph Nodes: Filter lymph, house immune cells.

Phagocytosis

Phagocytosis is the process by which immune cells ingest and destroy pathogens.

  • Steps: Chemotaxis, adherence, ingestion, digestion, discharge of waste.

  • Some microbes evade phagocytosis via capsules or other mechanisms, complicating infection control.

Inflammation

  • Definition: Localized response to injury or infection.

  • Acute vs. Chronic: Acute is short-term; chronic is prolonged and damaging.

  • Three Stages: Vasodilation, phagocyte migration, tissue repair.

  • Histamine: Increases blood vessel permeability, promoting inflammation.

Fever

  • Increased body temperature due to infection.

  • Blood vessels constrict, metabolism increases, shivering generates heat.

  • Cytokines mediate fever; can help fight infection but may be harmful if excessive.

Interferons

  • Proteins produced in response to viral infection.

  • Induce uninfected cells to produce antiviral proteins, limiting viral spread.

Adaptive Immunity

Overview and Definitions

Adaptive immunity provides specific, long-lasting protection through the actions of lymphocytes and the production of antibodies.

  • Two Components: Humoral and cellular immunity.

Humoral Immunity

  • Antibodies: Proteins produced by B cells in response to antigens.

  • B Cells: Produce antibodies and memory cells for future exposures.

  • Antigen: Substance that elicits an immune response.

  • Antibody: Protein that binds specifically to an antigen.

Cellular Immunity

  • T Cells: Mediate cellular immunity.

  • T Helper (TH) Cells: Activate other immune cells.

  • Cytotoxic T Lymphocytes (CTLs): Kill infected or abnormal cells.

  • Important for pathogens hiding inside cells or for eliminating cancerous cells.

Types of Adaptive Immunity

Type

How Acquired

Example

Naturally Acquired Active

Infection

Chickenpox recovery

Naturally Acquired Passive

Maternal antibodies

Placental transfer

Artificially Acquired Active

Vaccination

MMR vaccine

Artificially Acquired Passive

Injection of antibodies

Antivenom

Vaccines

Overview

Vaccines stimulate adaptive immunity to provide protection against specific pathogens.

  • Adjuvant: Substance added to enhance immune response.

  • Monoclonal Antibody: Laboratory-produced antibody for diagnostics or therapy.

  • Vaccines can target viruses, bacteria, or both.

Types of Vaccines

  • Live Attenuated: Weakened form of the pathogen.

  • Inactivated: Killed pathogen.

  • Subunit: Contains only parts of the pathogen.

  • Toxoid: Inactivated toxins.

  • Conjugate: Linked to a carrier protein.

Some types may pose risks if the pathogen reverts to virulence or in immunocompromised individuals.

Improving Vaccine Efficacy

  • Use of adjuvants

  • Booster doses

  • Recombinant technology

Immunological-Based Tests

  • Detect antibodies or antigens in patient samples.

  • Examples: ELISA, rapid strep test.

  • Positive result indicates presence of pathogen or immune response.

Antimicrobial Drugs

Overview and Terminology

  • Chemotherapy: Use of chemicals to treat disease.

  • Antimicrobial Drugs: Compounds that kill or inhibit microbes.

  • Antibiotic: Substance produced by microorganisms that inhibits others.

Selective Toxicity

Drugs should target microbes without harming human cells.

Bactericidal vs. Bacteriostatic

  • Bactericidal: Kills bacteria.

  • Bacteriostatic: Inhibits bacterial growth.

Antibiotics and Viruses

  • Antibiotics do not kill viruses (e.g., cold, influenza, COVID-19).

Targets of Antimicrobial Drugs

  • Cell Wall Synthesis: Penicillins, cephalosporins; bacteria may resist via beta-lactamase production.

  • Protein Synthesis: Tetracyclines, macrolides.

  • Plasma Membrane: Polymyxins.

  • Nucleic Acid Synthesis: Quinolones, rifampin.

  • Metabolic Pathways: Sulfonamides.

Antifungal and Antiviral Drugs

  • Antifungals: Target ergosterol in fungal membranes (e.g., amphotericin B).

  • Antivirals: Inhibit viral replication (e.g., acyclovir for herpes).

Antimicrobial Drug Synergy

  • Combined use of drugs for enhanced effect (e.g., trimethoprim-sulfamethoxazole).

Antibiotic Resistance

  • Occurs via mutation or gene transfer.

  • Human factors: Overuse, misuse, incomplete courses.

  • Mechanisms: Enzyme production (e.g., beta-lactamase), altered targets, efflux pumps.

  • Example: MRSA (Methicillin-resistant Staphylococcus aureus).

Figure 20.17: Disk diffusion method for testing antibiotic susceptibility.

Table 20.3: (Common antimicrobial drugs and their actions.)

Drug

Target

Example Disease

Penicillin

Cell wall synthesis

Strep throat

Tetracycline

Protein synthesis

Acne

Polymyxin B

Plasma membrane

Pseudomonas infection

Rifampin

RNA synthesis

Tuberculosis

Additional info: For all tables, content is inferred and representative based on standard microbiology textbooks.

Pearson Logo

Study Prep